<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="migraine/PMC6520671/results/search/disease/results.xml">
  <result pre="positively influence other pathways commonly believed to be part of" exact="migraine" post="pathophysiology, namely: mitochondrial functioning, oxidative stress, cerebral excitability, inflammation"/>
  <result pre="the presence of KBs, D-BHB in particular, could influence those" exact="migraine" post="pathophysiological mechanisms. To this end, common abnormalities in migraines"/>
  <result pre="elaborate on the potential therapeutic mechanisms of elevated KBs in" exact="migraine" post="pathophysiology, with a particular focus on the actions of"/>
  <result pre="of KBs, or both, are of primary importance for the" exact="migraine" post="protective effects of the KD. migraine beta-hydroxybutyrate ketone bodies"/>
  <result pre="primary importance for the migraine protective effects of the KD." exact="migraine" post="beta-hydroxybutyrate ketone bodies ketosis migraine prevention ketogenic diet exogenous"/>
  <result pre="protective effects of the KD. migraine beta-hydroxybutyrate ketone bodies ketosis" exact="migraine" post="prevention ketogenic diet exogenous ketone bodies 1. Introduction Migraine"/>
  <result pre="bodies 1. Introduction Migraine is a complex, common and debilitating" exact="neurological disorder" post="[ 1]. Its episodic form is characterized by recurrent"/>
  <result pre="a peak incidence during the most productive years of life," exact="migraine" post="not only causes a huge amount of suffering, but"/>
  <result pre="billion per year in Europe alone [ 3, 4]. Current" exact="migraine" post="treatment options have limited efficacy and many—often intolerable—side-effects ["/>
  <result pre="least partially—an energy deficit syndrome of the brain, and the" exact="migraine" post="attack a response to increased oxidative stress and/or (cerebral)"/>
  <result pre="30, 31, 32]). Several case studies have demonstrated the potentially" exact="migraine" post="protective effects of ketosis [ 22, 33, 34, 35,"/>
  <result pre="36, 37]. A one-month observational study of KD in 96" exact="migraine" post="patients as part of a weight loss program found"/>
  <result pre="loss program found a reduction of up to 80% in" exact="migraine" post="frequency, severity and acute medication use [ 37]. The"/>
  <result pre="intervention in 18 episodic migraineurs induced a 62.5% reduction in" exact="migraine" post="days, which was accompanied by a normalization of the"/>
  <result pre="deficit of visual evoked responses [ 36]. The reduction in" exact="migraine" post="attack frequency, severity and the use of acute anti-migraine"/>
  <result pre="ketosis [ 33], as is often the case in pediatric" exact="epilepsy" post="patients, and could be the result of longer-lasting gene-expression"/>
  <result pre="the presence of ketone bodies, D-BHB in particular, could influence" exact="migraine" post="pathophysiology (see Figure 1). To this end, common abnormalities"/>
  <result pre="pathophysiology (see Figure 1). To this end, common abnormalities in" exact="migraine" post="(such as abnormalities in glucose metabolism and transport, mitochondrial"/>
  <result pre="elaborate on the potential therapeutic mechanisms of elevated KBs in" exact="migraine" post="pathophysiology with a particular focus on the actions of"/>
  <result pre="Mechanisms of Ketosis 2.1. Hypoglycemia/Hypometabolism Hypoglycaemia has been associated with" exact="migraine" post="for almost a century [ 39, 40, 41] and"/>
  <result pre="a meal is not only amongst the most commonly cited" exact="migraine" post="triggers [ 42, 43, 44], but it can also"/>
  <result pre="44], but it can also be used experimentally to elicit" exact="migraine" post="attacks in susceptible patients [ 39]. Due to very"/>
  <result pre="especially vulnerable to their potential short-comings. A simple comparison between" exact="migraine" post="associated symptoms, premonitory symptoms in particular, and symptoms of"/>
  <result pre="cognitive difficulties, tiredness, fatigue, visual dysfunction and slurred speech. Increased" exact="migraine" post="frequency has also been observed during Ramadan [ 46]"/>
  <result pre="frequency has also been observed during Ramadan [ 46] and" exact="migraine" post="prevalence in type 2 diabetics was shown to proportionally"/>
  <result pre="for the role of energy deficiency and/or glucose metabolism in" exact="migraine" post="comes from neuroimaging studies. Using 31P-MRS, an impairment of"/>
  <result pre="impairment of brain oxidative phosphorylation (OXPHOS) was detected first during" exact="migraine" post="attacks [ 48] and thereafter between attacks [ 49,"/>
  <result pre="52, 53, 54, 55, 56]. OXPHOS abnormalities in patients with" exact="migraine" post="were found both in the resting brain and in"/>
  <result pre="More recently, a 16% decrease of absolute ATP levels in" exact="migraine" post="without aura patients was demonstrated interictally using 31P-MRS ["/>
  <result pre="exceeded glucose uptake in visual areas in 90% of interictal" exact="migraine" post="without aura patients, but in only 15% of healthy"/>
  <result pre="brain activity and glucose metabolism may be a cornerstone of" exact="migraine" post="pathophysiology. KBs are known to be able to counteract"/>
  <result pre="be able to counteract some of the negative effects of" exact="hypoglycemia" post="and/or hypometabolism or prevent it all together. D-BHB has"/>
  <result pre="oral glucose tolerance tests after an overnight fast can elicit" exact="migraine" post="attacks in susceptible patients [ 68, 69]. Interestingly, the"/>
  <result pre="in migraine. GLUT1 deficiency syndrome has been linked to hemiplegic" exact="migraine" post="and migraine with aura [ 70]. GLUT4 (adipose tissue"/>
  <result pre="GLUT1 deficiency syndrome has been linked to hemiplegic migraine and" exact="migraine" post="with aura [ 70]. GLUT4 (adipose tissue and striated"/>
  <result pre="the cells. Interictal impaired glucose tolerance and insulin resistance in" exact="migraine" post="has been reported in various studies [ 72, 73,"/>
  <result pre="Some genetic support for a potential role of insulin in" exact="migraine" post="comes from associations between polymorphisms in insulin-related genes and"/>
  <result pre="migraine comes from associations between polymorphisms in insulin-related genes and" exact="migraine" post="[ 79, 80, 81, 82]. KBs are taken up"/>
  <result pre="a role of mitochondrial functioning in migraine. The prevalence of" exact="migraine" post="in mitochondrial disorders is more than doubled (29–35.5% of"/>
  <result pre="patients) [ 87, 88] and migraine-like attacks in Mitochondrial encephalomyopathy," exact="lactic acidosis," post="and stroke-like episodes (MELAS) are especially severe and prolonged"/>
  <result pre="are especially severe and prolonged [ 89]. Maternal transmission in" exact="migraine" post="is more common [ 90], which suggests that either"/>
  <result pre="mtDNA derives exclusively from maternal origin. Furthermore, enrichment of a" exact="migraine" post="genome-wide association study (GWAS) signal was found for mitochondria"/>
  <result pre="that identifies a genetic link between mitochondrial function and common" exact="migraine" post="[ 91]. Further support for a generalized metabolic dysfunction"/>
  <result pre="[ 91]. Further support for a generalized metabolic dysfunction in" exact="migraine" post="comes from the reduced activity of mitochondrial enzymes, such"/>
  <result pre="succinate-dehydrogenase, NADH-dehydrogenase, cyclooxygenase (COX) and citrate-synthetase in the platelets of" exact="migraine" post="patients with and without aura [ 92, 93]. Interestingly,"/>
  <result pre="in migraine. Most nutraceuticals that have been demonstrated to be" exact="migraine" post="preventative can directly be linked to energy metabolism and/or"/>
  <result pre="and magnesium [ 113]. Even pharmaceutical prophylactic agents used against" exact="migraine" post="are able to influence mitochondrial functioning and metabolism. For"/>
  <result pre="and Valproate preserves mitochondrial function in a rat model of" exact="migraine" post="[ 118] and increases mitochondrial biogenesis [ 119]. KBs"/>
  <result pre="it exceeds the anti-oxidant capacity of the organism. All common" exact="migraine" post="triggers (stress/relaxation thereafter, fasting/skipping a meal, sleep changes (too"/>
  <result pre="highly pro-oxidant and accumulates in the brain stem nuclei of" exact="migraine" post="patients proportionally to disease duration [ 129]. Other heavy"/>
  <result pre="heavy metals with pro-oxidant properties may also be increased in" exact="migraine" post="[ 130]. Increased oxidative/nitrosative stress and/or decreased anti-oxidant capacity"/>
  <result pre="and/or decreased anti-oxidant capacity have also directly been found in" exact="migraine" post="patients [ 117, 131, 132, 133, 134, 135, 136,"/>
  <result pre="superoxide dismutase (SOD) activity seems to be consistently reduced in" exact="migraine" post="patients, also interictally [ 144]. Reduced anti-oxidant capacity or"/>
  <result pre="[ 144]. Reduced anti-oxidant capacity or increased oxidative stress in" exact="migraine" post="could be related to a genetic predisposition. A polymorphism"/>
  <result pre="SOD2 gene was associated with unilateral cranial autonomic symptoms in" exact="migraine" post="with aura patients [ 145], and in paediatric migraine"/>
  <result pre="in migraine with aura patients [ 145], and in paediatric" exact="migraine" post="patients’ polymorphisms in the SOD2 and catalase gene were"/>
  <result pre="the SOD2 and catalase gene were significantly higher in both" exact="migraine" post="with and without aura patients compared to controls ["/>
  <result pre="146]. Further support for the role of oxidative stress in" exact="migraine" post="is that as aforementioned antioxidants, such as Coenzyme Q10"/>
  <result pre="acid) [ 107, 108, 109] have been shown to have" exact="migraine" post="protective effects. The elevation of KBs, D-BHB in particular,"/>
  <result pre="be hypothesized that the aforementioned increased KB levels during a" exact="migraine" post="attack [ 68, 69] could represent an analogous reaction"/>
  <result pre="KD is known to be effective as treatment for refractory" exact="epilepsy" post="[ 157]. There is comorbidity and shared genetic susceptibility"/>
  <result pre="[ 157]. There is comorbidity and shared genetic susceptibility between" exact="migraine" post="and epilepsy [ 158] and hence partially similar pathophysiologic"/>
  <result pre="There is comorbidity and shared genetic susceptibility between migraine and" exact="epilepsy" post="[ 158] and hence partially similar pathophysiologic mechanisms are"/>
  <result pre="be a pathogenic cornerstone in migraine, as it is in" exact="epilepsy" post="[ 160, 161, 162, 163, 164]. The genetic association"/>
  <result pre="[ 160, 161, 162, 163, 164]. The genetic association between" exact="migraine" post="and epilepsy is illustrated by their co-occurrence in the"/>
  <result pre="161, 162, 163, 164]. The genetic association between migraine and" exact="epilepsy" post="is illustrated by their co-occurrence in the hitherto known"/>
  <result pre="by their co-occurrence in the hitherto known three subtypes of" exact="familial hemiplegic migraine" post="(FHM), a rare autosomal dominant monogenic form of migraine."/>
  <result pre="co-occurrence in the hitherto known three subtypes of familial hemiplegic" exact="migraine" post="(FHM), a rare autosomal dominant monogenic form of migraine."/>
  <result pre="inhibitory interneurons (FHM3—SCN1A) [ 168]. In the common forms of" exact="migraine" post="with and without aura, GWAS have identified 38 susceptibility"/>
  <result pre="which may lead to a &quot;generalized&quot; neuronal hyperexcitability of the" exact="migraine" post="brain. The observation that increased KB metabolism produces seizure"/>
  <result pre="inhibition as well as a reduction in excitability could be" exact="migraine" post="protective. 2.6. Cortical Spreading Depression Cortical spreading depression (CSD)"/>
  <result pre="and has been implicated as the underlying pathophysiological mechanism in" exact="migraine" post="aura. CSD susceptibility is strongly modulated by metabolic factors."/>
  <result pre="or injury. Even though the involvement of neurogenic inflammation in" exact="migraine" post="remains controversial [ 186], and migraine has not classically"/>
  <result pre="of neurogenic inflammation in migraine remains controversial [ 186], and" exact="migraine" post="has not classically been considered an inflammatory disease, possibly"/>
  <result pre="involvement of pro-inflammatory peptides or a &quot;sterile neurogenic inflammation&quot; in" exact="migraine" post="pain (review [ 187, 188]). Most importantly, calcitonin gene"/>
  <result pre="some extent cytokines [ 199], are all molecules associated with" exact="migraine" post="both in animal and human studies review [ 187,"/>
  <result pre="Cytokine Polymorphism (TNF-α and IL-1β gene polymorphisms) in patients with" exact="migraine" post="without aura provide some more suggestive evidence for a"/>
  <result pre="more suggestive evidence for a possible contribution of inflammation in" exact="migraine" post="[ 201]. Meningeal mast cell activation has been discussed"/>
  <result pre="discussed to play a role in meningeal nociceptor activation in" exact="migraine" post="[ 202]. D-BHB was reported to reduce inflammation generated"/>
  <result pre="the KD [ 205, 206, 207], which could further be" exact="migraine" post="protective. 2.8. Gut Microbiome The potential role of the"/>
  <result pre="2.8. Gut Microbiome The potential role of the microbiome in" exact="migraine" post="pathophysiology is not yet fully established. Two recent reviews"/>
  <result pre="an increased frequency of gastrointestinal (GI) symptoms or disorders in" exact="migraine" post="patients compared to the general population, such as increased"/>
  <result pre="increased rates of nausea, cyclic vomiting syndrome, inflammatory bowel syndrome," exact="irritable bowel syndrome," post="celiac disease, gastroparesis, hepatobiliary disorders, helicobacter pylori infection, gastric"/>
  <result pre="patients using a multispecies probiotic showed a significant reduction in" exact="migraine" post="days, headache intensity and the use of painkillers ["/>
  <result pre="painkillers [ 212]. Additionally, an immunoglobulin-G based elimination diet among" exact="migraine" post="patients with irritable bowel syndrome was associated with significant"/>
  <result pre="Additionally, an immunoglobulin-G based elimination diet among migraine patients with" exact="irritable bowel syndrome" post="was associated with significant reductions in attack frequency, duration,"/>
  <result pre="severity and medication use [ 213]. Possible underlying mechanisms of" exact="migraine" post="and GI diseases could be inflammation, alterations in the"/>
  <result pre="well as increased gut permeability. The role of inflammation in" exact="migraine" post="as well as the anti-inflammatory effects of ketosis have"/>
  <result pre="recently been shown that a KD in children with severe" exact="epilepsy" post="alters the gut microbiome [ 214, 215]. Recent experiments"/>
  <result pre="[ 216]. In support of this, in infants with refractory" exact="epilepsy" post="a KD decreased seizure frequency in the majority of"/>
  <result pre="normalization of the microbiota in two other neurological disorders, namely" exact="autism" post="[ 218] and multiple sclerosis [ 219]. In the"/>
  <result pre="in two other neurological disorders, namely autism [ 218] and" exact="multiple sclerosis" post="[ 219]. In the BTBRT+tf/j mouse model of autism"/>
  <result pre="multiple sclerosis [ 219]. In the BTBRT+tf/j mouse model of" exact="autism" post="spectrum disorder, a KD significantly increased the Firmicutes/Bacteroidetes ratio"/>
  <result pre="significantly increased the Firmicutes/Bacteroidetes ratio which is typically low in" exact="autism" post="spectrum disorder and also normalized the overabundance of the"/>
  <result pre="the mucin-degrading bacterium Akkermansia muciniphila [ 218]. In patients with" exact="multiple sclerosis" post="who were characterized by a reduced mass and diversity"/>
  <result pre="studies. For example, a small study on children with severe" exact="epilepsy" post="found that the relative abundance of bifidobacteria as well"/>
  <result pre="protein and carbohydrates and other factors. The children with severe" exact="epilepsy" post="were mostly on a very strict classical KD with"/>
  <result pre="genetic polymorphisms and in turn pathophysiological mechanisms contributing to the" exact="migraine" post="phenotype. We have reviewed the potential contribution of eight"/>
  <result pre="inflammation and (8) the microbiome. Which mechanisms contribute to the" exact="migraine" post="phenotype in a given individual are likely to vary."/>
  <result pre="importance of these metabolic mechanisms within the broad range of" exact="migraine" post="pathophysiology remains to be determined. With migraine being such"/>
  <result pre="broad range of migraine pathophysiology remains to be determined. With" exact="migraine" post="being such a diverse and multigenic disease, finding the"/>
  <result pre="have been shown to potentially influence all of the aforementioned" exact="migraine" post="pathophysiological mechanisms, might offer a long-needed relatively side-effect free"/>
  <result pre="relatively side-effect free remedy for at least a proportion of" exact="migraine" post="sufferers. It remains to be determined whether the absence/restriction"/>
  <result pre="KBs, or both, are of primary importance for the potentially" exact="migraine" post="protective effects of the KD that has previously been"/>
  <result pre="potentially disease-modifying effects of ketosis are actually also occurring in" exact="migraine" post="patients. Patents E.C.G. and D.F. are the inventors of"/>
  <result pre="and University of Basel on the use of beta-hydroxybutyrate in" exact="migraine" post="prevention. D.P.D. is inventor on International Patent # PCT/US2014/031237,"/>
  <result pre="R.B. Global perspectives on the burden of episodic and chronic" exact="migraine" post="Cephalalgia Int. J. Headache 2013 33 885 890 10.1177/0333102413477736"/>
  <result pre="1311 10.1111/head.12154 23879870 8. Pietrobon D. Moskowitz M.A. Pathophysiology of" exact="migraine" post="Annu. Rev. Physiol. 2013 75 365 391 10.1146/annurev-physiol-030212-183717 23190076"/>
  <result pre="Fischer D. Sandor P.S. Schoenen J. The metabilic face of" exact="migraine" post="Nat. Neurosci. 2019 7 50708 50718 10. Edmond J."/>
  <result pre="Thiele E.A. The use of diet in the treatment of" exact="epilepsy" post="Epilepsy Behav. E&amp;amp;B 2005 6 4 8 12. Danial"/>
  <result pre="14. Barañano K.W. Hartman A.L. The ketogenic diet: Uses in" exact="epilepsy" post="and other neurologic illnesses Curr. Treat. Opt. Neurol. 2008"/>
  <result pre="J.I. Sperling M.R. Ketogenic diet in adolescents and adults with" exact="epilepsy" post="Seizure 2014 23 439 442 10.1016/j.seizure.2014.02.015 24675110 20. Reid"/>
  <result pre="E.H. Ketosis and the ketogenic diet, 2010: Advances in treating" exact="epilepsy" post="and other disorders Adv. Pediatrics 2010 57 315 329"/>
  <result pre="H.-S. Medium-chain triglyceride ketogenic diet, an effective treatment for drug-resistant" exact="epilepsy" post="and a comparison with other ketogenic diets Biomed. J."/>
  <result pre="Rabier D. Ottolenghi C. et al. Successful treatment of severe" exact="cardiomyopathy" post="in glycogen storage disease type III With D,L-3-hydroxybutyrate, ketogenic"/>
  <result pre="Ottolenghi C. et al. Successful treatment of severe cardiomyopathy in" exact="glycogen storage disease" post="type III With D,L-3-hydroxybutyrate, ketogenic and high-protein diet Pediatric"/>
  <result pre="2056 2065 10.1016/j.bbadis.2015.07.009 26170063 33. Strahlman R.S. Can ketosis help" exact="migraine" post="sufferers? A case report Headache 2006 46 182 10.1111/j.1526-4610.2006.00321_5.x"/>
  <result pre="Cardillo A. De Nardis L. Pierelli F. Diet transiently improves" exact="migraine" post="in two twin sisters: Possible role of ketogenesis? Funct."/>
  <result pre="35. Maggioni F. Margoni M. Zanchin G. Ketogenic diet in" exact="migraine" post="treatment: A brief but ancient history Cephalalgia Int. J."/>
  <result pre="G. The ketogenic diet: Metabolic influences on brain excitability and" exact="epilepsy" post="Trends Neurosci. 2013 36 32 40 10.1016/j.tins.2012.11.005 23228828 39."/>
  <result pre="Blau J.N. Cumings J.N. Method of precipitating and preventing some" exact="migraine" post="attacks Br. Med. J. 1966 2 1242 1243 10.1136/bmj.2.5524.1242"/>
  <result pre="S.J. What turns on a migraine? A systematic review of" exact="migraine" post="precipitating factors Curr. Pain Headache Rep. 2014 18 454"/>
  <result pre="L.R. Helpern J.A. Preliminary observations on brain energy metabolism in" exact="migraine" post="studied by in vivo phosphorus 31 NMR spectroscopy Neurology"/>
  <result pre="shown by 31P magnetic resonance spectroscopy in patients affected by" exact="migraine" post="with aura Neurology 1992 42 1209 1214 10.1212/WNL.42.6.1209 1603349"/>
  <result pre="with low free magnesium in the brains of patients with" exact="migraine" post="and cluster headache Brain Res. Bull. 2001 54 437"/>
  <result pre="Frassineti C. Zaniol P. Lugaresi E. 31P-magnetic resonance spectroscopy in" exact="migraine" post="without aura Neurology 1994 44 666 669 10.1212/WNL.44.4.666 8164822"/>
  <result pre="Quantitative analysis of skeletal muscle bioenergetics and proton efflux in" exact="migraine" post="and cluster headache J. Neurol. Sci. 1997 146 73"/>
  <result pre="P. Martinelli P. Sacquegna T. Zaniol P. Lugaresi E. Complicated" exact="migraine" post="studied by phosphorus magnetic resonance spectroscopy Cephalalgia 1990 10"/>
  <result pre="a reduction in high-energy phosphates in the occipital lobe of" exact="migraine" post="without aura patients Cephalalgia Int. J. Headache 2011 31"/>
  <result pre="neuronal activation-to-resting glucose uptake ratio in the visual cortex of" exact="migraine" post="patients: A study comparing 18FDG-PET and visual evoked potentials"/>
  <result pre="Williamson D.H. Whitty C.W.M. Blood-glucose levels and fatty-acid metabolism in" exact="migraine" post="related to fasting Lancet 1971 297 1153 1156 10.1016/S0140-6736(71)91662-X"/>
  <result pre="R.H. Keogh H.J. Metabolic changes during glucose tolerance tests in" exact="migraine" post="attacks J. Neurol. Sci. 1977 33 51 59 10.1016/0022-510X(77)90181-2"/>
  <result pre="R. Pinessi L. Insulin sensitivity is impaired in patients with" exact="migraine" post="Cephalalgia 2005 25 593 597 10.1111/j.1468-2982.2005.00928.x 16033384 75. Fava"/>
  <result pre="Ermio C. De Bartolo M. Opipari C. et al. Chronic" exact="migraine" post="in women is associated with insulin resistance: A cross-sectional"/>
  <result pre="detected in the INSR gene in a chromosome 19p13 linked" exact="migraine" post="pedigree Eur. J. Med. Genet. 2006 49 57 62"/>
  <result pre="H. Nissilä M. et al. Chromosome 19p13 loci in Finnish" exact="migraine" post="with aura families Am. J. Med. Genet. B Neuropsychiatr."/>
  <result pre="alleles in the insulin receptor gene are associated with typical" exact="migraine" post="Genomics 2001 78 135 149 10.1006/geno.2001.6647 11735220 82. Netzer"/>
  <result pre="Kubisch C. Replication study of the insulin receptor gene in" exact="migraine" post="with aura Genomics 2008 91 503 507 10.1016/j.ygeno.2008.03.006 18455362"/>
  <result pre="of ketogenesis in cultured astroglia and neurons under hypoxia and" exact="hypoglycemia" post="ASN Neuro 2014 6 1759091414550997 10.1177/1759091414550997 25290061 85. Veggiotti"/>
  <result pre="co-expression analysis identifies brain regions and cell types involved in" exact="migraine" post="pathophysiology: A GWAS-based study using the Allen Human Brain"/>
  <result pre="Montagna P. Abnormal platelet mitochondrial function in patients affected by" exact="migraine" post="with and without aura Cephalalgia Int. J. Headache 1994"/>
  <result pre="Einhäupl K.M. Arnold G. High-dose riboflavin treatment is efficacious in" exact="migraine" post="prophylaxis: An open study in a tertiary care centre"/>
  <result pre="Arbizzani A. Parmeggiani A. Riboflavin prophylaxis in pediatric and adolescent" exact="migraine" post="J. Headache Pain 2009 10 361 365 10.1007/s10194-009-0142-2 19649688"/>
  <result pre="H.-C. Danesch U. collab: Migravent ® Study Group Improvement of" exact="migraine" post="symptoms with a proprietary supplement containing riboflavin, magnesium and"/>
  <result pre="J. Jacquy J. Lenaerts M. Effectiveness of high-dose riboflavin in" exact="migraine" post="prophylaxis. A randomized controlled trial Neurology 1998 50 466"/>
  <result pre="Tarighat-Esfanjani A. Efficacy of coenzyme Q10 for the prevention of" exact="migraine" post="in women: A randomized, double-blind, placebo-controlled study Eur. J."/>
  <result pre="L. Agosti R.M. Schoenen J. Efficacy of coenzyme Q10 in" exact="migraine" post="prophylaxis: A randomized controlled trial Neurology 2005 64 713"/>
  <result pre="M. The effects of concurrent Coenzyme Q10, L-carnitine supplementation in" exact="migraine" post="prophylaxis: A randomized, placebo-controlled, double-blind trial Cephalalgia 2019 6"/>
  <result pre="Oryani M. Effectiveness of coenzyme Q10 in prophylactic treatment of" exact="migraine" post="headache: An open-label, add-on, controlled trial Acta Neurol. Belg."/>
  <result pre="Silberstein S. Open label trial of coenzyme Q10 as a" exact="migraine" post="preventive Cephalalgia 2002 22 137 141 10.1046/j.1468-2982.2002.00335.x 11972582 107."/>
  <result pre="J. A randomized double-blind placebo-controlled trial of thioctic acid in" exact="migraine" post="prophylaxis Headache 2007 47 52 57 10.1111/j.1526-4610.2006.00626.x 17355494 108."/>
  <result pre="T.G. Al-Adl N.M. Efficacy of combined topiramate/thioctic acid therapy in" exact="migraine" post="prophylaxis Saudi Pharm. J. 2010 18 239 243 10.1016/j.jsps.2010.07.006"/>
  <result pre="of vitamin supplementation and MTHFR (C677T) genotype on homocysteine-lowering and" exact="migraine" post="disability Pharmacogenet. Genom. 2009 19 422 428 10.1097/FPC.0b013e32832af5a3 111."/>
  <result pre="MTHFR C677T and MTRR A66G genes act independently to reduce" exact="migraine" post="disability in response to vitamin supplementation Pharmacogenet. Genom. 2012"/>
  <result pre="mechanism of neuroprotection by topiramate in an animal model of" exact="epilepsy" post="Epilepsia 2004 45 1478 1487 10.1111/j.0013-9580.2004.13504.x 15571505 115. Motaghinejad"/>
  <result pre="Kalita J. Misra U.K. A study of oxidative stress in" exact="migraine" post="with special reference to prophylactic therapy Int. J. Neurosci."/>
  <result pre="A ketogenic diet as a potential novel therapeutic intervention in" exact="amyotrophic lateral sclerosis" post="BMC Neurosci. 2006 7 29 16584562 127. Kelman L."/>
  <result pre="of trace elements and heavy metals in patients with acute" exact="migraine" post="headache J. Pak. Med. Assoc. 2015 65 694 697"/>
  <result pre="A. Koçyiğit A. Oxidative and antioxidative balance in patients of" exact="migraine" post="Eur. Rev. Med. Pharmacol. Sci. 2010 14 877 882"/>
  <result pre="İnan L.E. Durak İ. Yoldaş T.K. Decreased antioxidant status in" exact="migraine" post="patients with brain white matter hyperintensities Neurol. Sci. 2014"/>
  <result pre="S. Fazekas F. et al. Oxidative stress is associated with" exact="migraine" post="and migraine-related metabolic risk in females Eur. J. Neurol."/>
  <result pre="A. Topaktas S. Bakir S. Intraerythrocyte antioxidant enzyme activities in" exact="migraine" post="and tension-type headaches J. Chin. Med. Assoc. 2004 67"/>
  <result pre="Taysi S. Oxidative stress and DNA damage in patients with" exact="migraine" post="J. Headache Pain 2016 17 10 10.1186/s10194-016-0606-0 26883365 139."/>
  <result pre="Deniz O. Erel O. A novel oxidative stress marker in" exact="migraine" post="patients: Dynamic thiol-disulphide homeostasis Neurol. Sci. 2016 37 1311"/>
  <result pre="Yücel D. Increased nitrosative and oxidative stress in platelets of" exact="migraine" post="patients Tohoku J. Exp. Med. 2007 211 23 30"/>
  <result pre="biomarkers related to oxidative stress and nitric oxide pathway in" exact="migraine" post="Cephalalgia 2015 35 931 937 10.1177/0333102414564888 25573894 145. Palmirotta"/>
  <result pre="Della-Morte D. et al. Is SOD2 Ala16Val polymorphism associated with" exact="migraine" post="with aura phenotype? Antioxid. Redox Signal. 2015 22 275"/>
  <result pre="Bessone S.K. Kossoff E.H.W. The ketogenic diet in pharmacoresistant childhood" exact="epilepsy" post="Expert Rev. Neurother 2015 15 621 628 10.1586/14737175.2015.1044982 25994046"/>
  <result pre="M.R. Connors R. Evidence for a shared genetic susceptibility to" exact="migraine" post="and epilepsy Epilepsia 2013 54 288 295 10.1111/epi.12072 23294289"/>
  <result pre="R. Evidence for a shared genetic susceptibility to migraine and" exact="epilepsy" post="Epilepsia 2013 54 288 295 10.1111/epi.12072 23294289 159. Coppola"/>
  <result pre="23294289 159. Coppola G. Pierelli F. Schoenen J. Habituation and" exact="migraine" post="Neurobiol. Learn. Mem. 2009 92 249 259 10.1016/j.nlm.2008.07.006 18675928"/>
  <result pre="160. Aurora S.K. Wilkinson F. The brain is hyperexcitable in" exact="migraine" post="Cephalalgia Int. J. Headache 2007 27 1442 1453 10.1111/j.1468-2982.2007.01502.x"/>
  <result pre="Franceschetti S. Mantegazza M. Self-limited hyperexcitability: Functional effect of a" exact="familial hemiplegic migraine" post="mutation of the Nav1.1 (SCN1A) Na+ channel J. Neurosci."/>
  <result pre="Mantegazza M. Self-limited hyperexcitability: Functional effect of a familial hemiplegic" exact="migraine" post="mutation of the Nav1.1 (SCN1A) Na+ channel J. Neurosci."/>
  <result pre="reveals hyperexcitability of the temporal pole in interictal and ictal" exact="migraine" post="States Cerebral Cortex 2011 21 435 448 10.1093/cercor/bhq109 20562317"/>
  <result pre="Vicaut E. Bousser M.G. Tournier-Lasserve E. The clinical spectrum of" exact="familial hemiplegic migraine" post="associated with mutations in a neuronal calcium channel New"/>
  <result pre="Bousser M.G. Tournier-Lasserve E. The clinical spectrum of familial hemiplegic" exact="migraine" post="associated with mutations in a neuronal calcium channel New"/>
  <result pre="Mohrenweiser H.W. Bulman D.E. Ferrari M. et al. Familial hemiplegic" exact="migraine" post="and episodic ataxia type-2 are caused by mutations in"/>
  <result pre="Bulman D.E. Ferrari M. et al. Familial hemiplegic migraine and" exact="episodic ataxia" post="type-2 are caused by mutations in the Ca2+ channel"/>
  <result pre="of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with" exact="familial hemiplegic migraine" post="type 2 Nat. Genet. 2003 33 192 196 10.1038/ng1081"/>
  <result pre="encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic" exact="migraine" post="type 2 Nat. Genet. 2003 33 192 196 10.1038/ng1081"/>
  <result pre="al. Mutation in the neuronal voltage-gated sodium channel SCN1A in" exact="familial hemiplegic migraine" post="Lancet 2005 366 371 377 10.1016/S0140-6736(05)66786-4 16054936 169. Anttila"/>
  <result pre="in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic" exact="migraine" post="Lancet 2005 366 371 377 10.1016/S0140-6736(05)66786-4 16054936 169. Anttila"/>
  <result pre="Freilinger T. Müller-Myhsok B. et al. Genome-wide association study of" exact="migraine" post="implicates a common susceptibility variant on 8q22.1 Nat. Genet."/>
  <result pre="al. Genome-wide association study reveals three susceptibility loci for common" exact="migraine" post="in the general population Nat. Genet. 2011 43 695"/>
  <result pre="W.P.J. et al. Genome-wide association analysis identifies susceptibility loci for" exact="migraine" post="without aura Nat. Genet. 2012 44 777 782 10.1038/ng.2307"/>
  <result pre="treatment. Targeting LDH enzymes with a stiripentol analog to treat" exact="epilepsy" post="Science 2015 347 1362 1367 10.1126/science.aaa1299 25792327 179. Won"/>
  <result pre="28707585 188. Ramachandran R. Neurogenic inflammation and its role in" exact="migraine" post="Semin. Immunopathol. 2018 40 301 314 10.1007/s00281-018-0676-y 29568973 189."/>
  <result pre="CGRP as a new target in prevention and treatment of" exact="migraine" post="Lancet. Neurol. 2014 13 1065 1067 10.1016/S1474-4422(14)70228-5 25297015 190."/>
  <result pre="Vasoactive peptide release in the extracerebral circulation of humans during" exact="migraine" post="headache Ann. Neurol. 1990 28 183 187 10.1002/ana.410280213 1699472"/>
  <result pre="B. Olesen J. CGRP may play a causative role in" exact="migraine" post="Cephalalgia Int. J. Headache 2002 22 54 61 10.1046/j.1468-2982.2002.00310.x"/>
  <result pre="A. Ashina M. CGRP, a target for preventive therapy in" exact="migraine" post="and cluster headache: Systematic review of clinical data Cephalalgia"/>
  <result pre="18789357 198. Olesen J. Ashina M. Can nitric oxide induce" exact="migraine" post="in normal individuals? Cephalalgia 2015 35 1125 1129 10.1177/0333102414566201"/>
  <result pre="Sendrowski K. Anti-inflammatory plasma cytokines in children and adolescents with" exact="migraine" post="headaches Pharmacol. Rep. 2010 62 287 291 10.1016/S1734-1140(10)70268-1 20508283"/>
  <result pre="200. Longoni M. Ferrarese C. Inflammation and excitotoxicity: Role in" exact="migraine" post="pathogenesis Neurol. Sci. 2006 27 s107 s110 10.1007/s10072-006-0582-2 16688611"/>
  <result pre="M.G. Witteman B.J.M. The effects of a multispecies probiotic on" exact="migraine" post="and markers of intestinal permeability-results of a randomized placebo-controlled"/>
  <result pre="functional composition of the gut microbiota in children with severe" exact="epilepsy" post="NPJ Biofilms Microbiomes 2019 5 5 10.1038/s41522-018-0073-2 30701077 215."/>
  <result pre="Wang Y. Altered gut microbiome composition in children with refractory" exact="epilepsy" post="after ketogenic diet Epilepsy Res. 2018 145 163 168"/>
  <result pre="significant effect on imbalanced gut microbiota in infants with refractory" exact="epilepsy" post="World J. Gastroenterol 2017 23 6164 6171 10.3748/wjg.v23.i33.6164 28970732"/>
  <result pre="diet modifies the gut microbiota in a murine model of" exact="autism" post="spectrum disorder Mol. Autism 2016 7 37 10.1186/s13229-016-0099-3 27594980"/>
  <result pre="trial Trials 2019 20 61 10.1186/s13063-018-3120-7 30654835 Figure 1 Potentially" exact="migraine" post="relevant mechanisms of ketosis. ( a) Amongst key migraine"/>
  <result pre="Potentially migraine relevant mechanisms of ketosis. ( a) Amongst key" exact="migraine" post="pathophysiological mechanisms are hypometabolism, decreased glucose transport (including glucose"/>
 </snippets>
</snippetsTree>
